Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neurovascular coupling in patients with relapsing-remitting multiple sclerosis.
Acute transverse myelitis: demyelinating, inflammatory, and infectious myelopathies.
Emerging oral agents for multiple sclerosis.
Improvements in cognition, quality of life, and physical performance with clinical Pilates in multiple sclerosis: a randomized controlled trial.
A Unified Frequency Domain Model to Study the Effect of Demyelination on Axonal Conduction.
Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a ...
Leisure time activities of Iranian patients with multiple sclerosis: a qualitative study.
PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate.
Pushing Forward: Remyelination as the New Frontier in CNS Diseases.
Chemotactic Cytokines: Gordon Research Conference on Molecular and Cellular Mechanisms in Health and Disease
Clinical proteomics of enervated neurons.
Extensive bilateral lower extremity deep venous thrombosis in a patient on dimethyl fumarate.
Retinyl Palmitate Supplementation Modulates T-bet and Interferon Gamma Gene Expression in Multiple Sclerosis Patients.
Insight into the mechanism of laquinimod action.
European Medicines Agency, Scientific Discussion of MabCampath (alemtuzumab)
Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder.
Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders.
Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound.
Molecular characterization of a peripheral receptor for cannabinoids.
Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial.
Clinical utility of testing AQP4-IgG in CSF: Guidance for physicians.
Patient centered decision making: Use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices.
Advanced Structural and Functional Brain MRI in Multiple Sclerosis.
Immunosuppressive properties of mesenchymal stem cells: advances and applications.
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.

Pages